To distinguish ABA clinical service quality improvement program evaluation case reports and research, examine the activity's actual purpose, prospective design, participant assignment, intervention, interaction, data source, identifiable information, intended use, and institutional coverage. Publication intent alone does not decide the category. A project may combine categories, so route ambiguous or mixed activities to the institution or reviewing body authorized to determine coverage before work begins.

Define Amina's governed activity and unit

Activity labels are working classifications that direct review; they are never substitutes for a source-supported institutional determination. Teams using this guide need the exact activity, people, purpose, design, data, site, sponsor, funding, institutional scope, authority, current version, participant protections, and unresolved facts before work begins.

Build Amina's activity-classification worksheet

Amina records the operational problem, clinical purpose, scientific question, target users, intervention status, comparison, prospective assignment, data already created, new data, participant contact, privacy level, intent to contribute to generalizable knowledge, expected dissemination, sponsor, funding, sites, FWA, governing policies, requested determination, decision owner, and date. Mixed projects keep more than one label and the strictest unresolved gate remains visible.

Protect participants and ordinary care in Amina's workflow

Amina's twenty proposed service, improvement, evaluation, case-description, and research projects must preserve client dignity, ordinary clinical access, voluntary choice, privacy, communication and AAC, authorized decision-making, safety response, equitable treatment, complaints, and freedom from retaliation. A research label, consent signature, payment, supervisor approval, or publication goal cannot expand a role or erase a required protection.

Work through Amina's fictional example

Amina reviews 20 activities: seven ordinary clinical-service changes, five QI efforts, three program evaluations, two case descriptions, and three research candidates. Eighteen receive documented routes. Two mixed projects remain held because their prospective intervention and cross-site generalization plans require institutional review. Preserve every proposed, classified, reviewed, approved, exempted, enrolled, changed, reported, published, corrected, held, withdrawn, and closed state with its original version, owner, date, conditions, and validation.

Use Amina's denominator carefully

Documented route completion is 18 of 20, or 90%. Category counts describe the reviewed cohort; they do not prove that every activity within a label shares the same legal or institutional status. The two unresolved projects stay in the original denominator.

Assign Amina's decisions to authorized owners

Amina can complete the worksheet and describe operations. The institution, IRB, or other authorized body makes formal research, human-subject, exemption, and review decisions. Clinical leaders decide service changes within scope, subject to those determinations and client protections.

Address Amina's main interpretation risk

Teams often call an activity QI because it occurs inside a clinic or research because someone hopes to publish. Both shortcuts miss purpose, design, interaction, identifiability, funding, and institutional coverage.

Verify Amina's research control in practice

Amina gives the same project packet to the operational owner and authorized reviewer, then compares the facts each used. A mismatch in purpose, data, assignment, site, or audience pauses the project until the record is reconciled.

Place Amina's project inside organizational accountability

Amina's activity-classification worksheet uses the CASP Organizational Guidelines public overview only for high-level business, clinical-operations, and risk-management scope in autism service organizations. CASP sells the detailed guidelines. The workflow here is Finni's editorial governance model, not a CASP research protocol, regulatory determination, or institutional approval.

Apply the BACB research duties to Amina's covered roles

Amina's role review uses the current BACB Ethics Code, which applies to BCBA and BCaBA certificants and people who completed an application. Its research section addresses applicable review, participant welfare, informed consent, confidentiality, competence, conflicts, integrity, authorship, publication, and corrections. BACB has no separate organization or corporation jurisdiction, so institutional and legal controls remain necessary.

Anchor Amina's federal scope to the current HHS rule

Amina's federal analysis starts with the HHS 45 CFR 46 page, reviewed in February 2025, which identifies the 2018 Requirements and added subparts for specified populations. Applicability depends on funding, conduct, assurance, institution, activity, and other facts. The page is an authoritative starting point, while the current rule and responsible institution control the determination.

Use the OHRP decision charts as aids for Amina

Amina's reviewer may use the OHRP 2018 Requirements decision charts to organize research, human-subject, exemption, continuing-review, and consent-waiver questions. OHRP calls the charts generalizations and directs users to the full applicable text. They support intake and discussion; they do not authorize an investigator to self-approve a project.

Classify quality improvement carefully for Amina

Amina's project label follows the OHRP Quality Improvement Activities FAQs. OHRP explains that intent to publish is insufficient to decide whether QI is research and that some QI can be nonexempt human-subjects research. Purpose, design, activity, coverage, and an authorized determination matter more than the label chosen by the project team.

Separate HIPAA research permission for Amina

Amina's privacy review uses HHS research guidance under HIPAA, which explains that covered entities may use or disclose PHI for research with individual authorization or through limited rule-defined paths without authorization. Common Rule consent, IRB action, HIPAA authorization or waiver, data-owner approval, and contract terms remain separate decisions even when one document combines information.

Treat informed consent as a process for Amina

Amina's communication plan draws on the OHRP Informed Consent FAQs. OHRP flags that the FAQ predates the 2018 Requirements and 2024 conforming changes, while retaining general nonbinding guidance. Use the current regulation and review decision. The FAQ describes prospective, legally effective, voluntary information exchange with questions and a real choice to join, continue, or withdraw.

Apply child-research requirements precisely for Amina

Amina's child-participant route uses current 45 CFR 46 Subpart D, amended in October 2024. The IRB determines adequate provisions for parental or guardian permission and for child assent when the child is capable, subject to the rule's conditions and possible waivers. Clinical assent policies and research assent determinations should be recorded separately.

Distinguish adverse events and unanticipated problems for Amina

Amina's incident logic uses OHRP guidance on unanticipated problems and adverse events. The guidance explains that only a subset of adverse events are unanticipated problems and describes unexpectedness, relation or possible relation, and increased risk as the three-part analysis. Use the current protocol, institution, and rules for actual reporting decisions and deadlines.

Scope research-misconduct handling for Amina

Amina's integrity route recognizes the 2024 final rule revising 42 CFR Part 93. The rule became effective January 1, 2025, and its regulatory requirements apply beginning January 1, 2026, to covered Public Health Service research-misconduct matters. Allegations received before that applicability date generally follow the 2005 rule unless the institution and respondent elect the new rule in writing. The current rule addresses fabrication, falsification, and plagiarism and excludes honest error or differences of opinion. Other sponsors, institutions, journals, employers, and laws can use different processes; preserve allegations as allegations until the authorized process decides them.

Make Amina's participation process accessible

Amina's access plan uses DOJ effective-communication guidance for covered title II or title III entities. The appropriate aid or service depends on the interaction's nature, length, complexity, context, and the person's usual communication method. Apply the actual entity and rule, preserve AAC and authorship, and test consent, recruitment, questions, incident notices, and withdrawal routes in the formats participants use.

Choose Amina's next review trigger

Reclassify after the question, design, population, data, site, funder, intervention, assignment, publication aim, or collaboration changes. Record the changed fact, affected people and records, immediate protection, governing source, decision owner, reporting or amendment route, deadlines, communication, and validation result.

Close Amina's record with accountable evidence

Review the activity-classification worksheet with Amina, investigators, qualified clinicians, the institution or reviewing body, participant representatives as applicable, and the specialists named in the manifest. Confirm that service, QI, evaluation, research, review, consent, privacy, safety, data, employment, authorship, publication, and misconduct routes remain distinct; all conditions are traceable; access is tested; and unresolved work has an accountable endpoint. Keep this page draft and noindex until every required review is complete.

Related resources

Sources